EUVIMEDEUVIMED entdecken
Open Access

Outcomes of frail patients undergoing high‐dose chemotherapy and autologous stem cell transplantation for multiple myeloma

Stephanie Yohay iD, Temitope Oloyede, Soyoung Kim, Xi Fang, Binod Dhakal iD, Ayesha Aijaz, Meera Mohan iD, Ravi Narra, Marcelo Pasquini iD, Anita D'Souza iD, Mehdi Hamadani iD, Ciara Louise Freeman und 1 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Stephanie Yohay und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, Hematopoietic Stem Cell Transplantation, Transplantation, Autologous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, National Heart, Lung and Blood Institute (NHLBI), Office of Naval Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients with multiple myeloma (MM) not‐eligible for autologous haematopoietic cell transplantation (autoHCT), a simplified frailty index (SFI) identifies frail patients at risk for poor outcomes, but data are limited for transplant‐eligible patients. In this registry‐based retrospective study, we used an adapted version of the SFI to determine the prevalence of frailty in patients ≥65 years of age with MM undergoing autoHCT. Out of 5563 patients, 37.9% of patients were classified as frail and although they had increased non‐relapse mortality (NRM) and inferior overall survival, the NRM at 100 days remained low (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHematopoietic Stem Cell TransplantationTransplantation, AutologousHumansAgedMaleFemaleRetrospective StudiesFrailtyTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsAged, 80 and over

Stichwörter der Autor:innen

BMTautologous stem cell transplantationfrailtymultiple myelomasurvival

Autor:innen und Institutionen

  • Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Center for International Blood and Marrow Transplantation, Milwaukee, Wisconsin, USA.
  • Yale University, New Haven, Connecticut, USA.
  • We Care Scan Center, Srinagar, Kashmir, India.
  • Moffitt Cancer Center, Tampa, Florida, USA.

ORCID-Profile: Stephanie Yohay, Binod Dhakal, Meera Mohan, Marcelo Pasquini, Anita D'Souza, Mehdi Hamadani, Othman Salim Akhtar

Förderung

  • NIEHS NIH HHS
  • National Heart, Lung and Blood Institute (NHLBI)
  • Office of Naval Research
  • NCI NIH HHS
  • National Cancer Institute (NCI)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • Health Resources and Services Administration (HRSA)
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Yohay, S., Oloyede, T., Kim, S., Fang, X., Dhakal, B., Aijaz, A., Mohan, M., Narra, R., Pasquini, M., D'Souza, A., Hamadani, M., Freeman, C. L., & Akhtar, O. S. (2024). Outcomes of frail patients undergoing high‐dose chemotherapy and autologous stem cell transplantation for multiple myeloma. British Journal of Haematology. https://doi.org/10.1111/bjh.19811

Vancouver

Yohay S, Oloyede T, Kim S, Fang X, Dhakal B, Aijaz A, et al. Outcomes of frail patients undergoing high‐dose chemotherapy and autologous stem cell transplantation for multiple myeloma. British Journal of Haematology. 2024. doi:10.1111/bjh.19811

BibTeX
@article{Yohay2024,
  author = {Yohay, Stephanie and Oloyede, Temitope and Kim, Soyoung and Fang, Xi and Dhakal, Binod and Aijaz, Ayesha and Mohan, Meera and Narra, Ravi and Pasquini, Marcelo and D'Souza, Anita and Hamadani, Mehdi and Freeman, Ciara Louise and Akhtar, Othman Salim},
  title = {Outcomes of frail patients undergoing high‐dose chemotherapy and autologous stem cell transplantation for multiple myeloma},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19811}
}
Kostenlos starten →